Dr. Lindsey's Multiple Sclerosis Website

ACTRIMS Forum 2017
Home
ECTRIMS 2017
ACTRIMS Forum 2017
ECTRIMS 2016
Tecfidera update September, 2016
ECTRIMS 2015
AAN 2015
ACTRIMS-ECTRIMS 2014
AAN 2014
Current Treatments (updated 7/7/13)
Gilenya (updated 4/20/2012)
Tysabri and PML
Ampyra
Recent and current research
Old meetings
New diagnosis of MS
Multiple Sclerosis Basic Information
Interferon versus Glatiramer--update 11/07
Talk on stem cells--2/13/08
About Dr. Lindsey
Research Interests
Map/Directions
Links
Clinic information
Contact Us

IMG_0131rotated.jpg

The second ACTRIMS Forum was held February 23 to 25, 2017 in Orlando, Florida.  ACTRIMS is the North American counterpart to ECTRIMS, and holds an annual meeting each year.  This meeting focused on the scientific aspects of MS.

There were a number of interesting presentations.  The keynote lecture was given by Dr. Hauser of UCSF, and was on the role of B cells in MS.  This is a very timely topic since a B cell depleting antibody, ocrelizumab, is likely to be approved soon in the US. 

There was an interesting session on diet and MS.  Dr. Ralf Linker gave an interesting talk on the effects of dietary fat in MS, which combined work in mice, in tissue culture and in humans.   He investigated the effect of short chain fatty acids, mainly propionic acid, on the immune system.  Adding propionic acid has several immune regulatory effects in tissue culture and decreases disease in the mouse model of MS.  This may be a future therapy for MS.  Interestingly, a high fiber diet increases the amount of propionic acid in the gut, through the action of gut bacteria, and might have the same effects as administering the propionic acid directly.  Other talks included the effects of vitamin D and salt on MS. 

I found the session on infections and MS particularly interesting.  Three different speakers discussed different viruses that have been linked to MS.  Dr. Dolei discussed endogenous retroviruses.  These are viruses that have inserted themselves into our DNA and become part of the human genome.  Most are no longer functional and don’t express any proteins, but some can make proteins or even whole virus.  One, called MSRV, is particularly strongly linked to MS and might play a role in causing disease.  An antibody against this virus is currently in testing.  Dr. Jacobson discussed HHV-6 in MS.  This is a herpesvirus that infects almost everyone, and establishes a latent infection in the brain.  Finally, Dr. Ascherio discussed Epstein-Barr virus in MS.  He strongly asserted, based on the evidence his group has accumulated over the years, that EBV is involved in causing MS.  I hope he is right, since I have spent the last 10 years of my career working on EBV in MS. 

The final session I will comment on is the microbiome in MS.  This has been an active area of research for the last several years.  The microbiome is essentially all the bacteria and other organisms which live on us, mainly in our gut.  Our gut bacteria have a surprising influence on our health, and can affect the activity of the immune system.  Conversely, we change our gut bacteria by what we eat and also when we take antibiotics.  People with MS have different bacteria in their gut than healthy people, and investigators are making the first attempts to change the bacteria in the gut.  This area is in a very early stage, since we still don’t know what types of bacteria are good for us.  

J. William Lindsey, MD
University of Texas Multiple Sclerosis Research Group
Houston, Texas

copyright 2007-2017 John William Lindsey